Invex Therapeutics Ltd (ASX: IXC)
Health Care · Pharmaceuticals · AU
AU$0.11
-4.35% today · -26.7% 1Y
Invex Therapeutics Ltd (ASX: IXC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.77M and employs 4 people.
Over the last twelve months the share price has lost 26.7%, trading between 0.09 and 0.15.
Tweenvest scores Invex Therapeutics Ltd across four factors: quality 48/100, value 42/100. Its strongest factor is quality.
IXC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.77M
- Revenue (TTM)
- $32.39K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.52
- 52-week high
- AU$0.15
- 52-week low
- AU$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 75.15M
- Employees
- 4
- Next earnings
- —
About Invex Therapeutics Ltd
Invex Therapeutics Ltd is an Australian biopharmaceutical company dedicated to researching and developing innovative treatments for various neurological disorders. Their primary focus is Exenatide, a promising therapeutic agent aimed at neurological conditions linked to or resulting from elevated intracranial pressure, including idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. Exenatide has successfully advanced through Phase II clinical trials. The company was founded in 2019 and operates from Perth, Australia.
- ISIN
- AU0000048621
- Founded
- 2019
- Listed since
- Jul 5, 2019
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc.NasdaqCM: SNOA | $5.89M | $1.23 | +6.03% |
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.52 | -0.02% |
| Firebrick Pharma LimitedASX: FRE | $5.81M | AU$0.03 | +3.57% |
| Panacea Life Sciences Holdings, Inc.OTCPK: PLSH | $5.78M | $0.09 | +6.25% |
| ECS Botanics Holdings LtdASX: ECS | $5.59M | AU$0.01 | -9.09% |
| Lamdong Pharmaceutical Joint Stock CompanyHNX: LDP | $5.50M | ₫7,600.00 | -1.30% |
| Lexaria Bioscience Corp.NasdaqCM: LEXX | $5.49M | $3.32 | +15.28% |
| Glow Lifetech Corp.CNSX: GLOW | $5.39M | CA$0.04 | -11.11% |
Figures last refreshed Oct 11, 2026.